Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer

Ethan B. Ludmir; Zachary R. McCaw; Lee Jen Wei

doi:10.1016/j.eururo.2020.09.049

Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer

Ethan B. Ludmir, Zachary R. McCaw, Lee Jen Wei

GI Radiation Oncology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	e10-e11
Journal	European urology
Volume	79
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2020.09.049
State	Published - Jan 2021

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2020.09.049

Cite this

Ludmir, E. B., McCaw, Z. R., & Wei, L. J. (2021). Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer. European urology, 79(1), e10-e11. https://doi.org/10.1016/j.eururo.2020.09.049

Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer. / Ludmir, Ethan B.; McCaw, Zachary R.; Wei, Lee Jen.
In: European urology, Vol. 79, No. 1, 01.2021, p. e10-e11.

Research output: Contribution to journal › Letter › peer-review

Ludmir, EB, McCaw, ZR & Wei, LJ 2021, 'Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer', European urology, vol. 79, no. 1, pp. e10-e11. https://doi.org/10.1016/j.eururo.2020.09.049

Ludmir EB, McCaw ZR, Wei LJ. Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer. European urology. 2021 Jan;79(1):e10-e11. doi: 10.1016/j.eururo.2020.09.049

Ludmir, Ethan B. ; McCaw, Zachary R. ; Wei, Lee Jen. / Re : Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer. In: European urology. 2021 ; Vol. 79, No. 1. pp. e10-e11.

@article{ad02c38dc1ff4fb2856b07525420b60e,

title = "Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer",

author = "Ludmir, {Ethan B.} and McCaw, {Zachary R.} and Wei, {Lee Jen}",

year = "2021",

month = jan,

doi = "10.1016/j.eururo.2020.09.049",

language = "English (US)",

volume = "79",

pages = "e10--e11",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Re

T2 - Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer

AU - Ludmir, Ethan B.

AU - McCaw, Zachary R.

AU - Wei, Lee Jen

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85095994760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095994760&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2020.09.049

DO - 10.1016/j.eururo.2020.09.049

M3 - Letter

C2 - 33109378

AN - SCOPUS:85095994760

SN - 0302-2838

VL - 79

SP - e10-e11

JO - European urology

JF - European urology

IS - 1

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this